Research Article
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
Alicia Marín-Candón et al.
DOI: 10.1136/bmjopen-2021-049481